股市 - Master Financial Information

努力突破重危量滾量量能放大期開得勝噴發向上產品傲視全球💪加油🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀... 繼續閱讀

努力突破重危量滾量量能放大期開得勝噴發向上產品傲視全球💪加油🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

量滾量努力噴發向上💪加油火力全開🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥... 繼續閱讀

量滾量努力噴發向上💪加油火力全開🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥

又有人要換車了嗎？反正匯率不好，錢先拿到手再說，
對了，順便記得標示好那些賣不出去的即期產品是南部哪家工廠生產的，... 繼續閱讀

又有人要換車了嗎？反正匯率不好，錢先拿到手再說，
對了，順便記得標示好那些賣不出去的即期產品是南部哪家工廠生產的，
不然紀念品怎麼會被別人說裡面有骨粉呢？

繼續閱讀

有人發瘋囉！ 真口憐😭

繼續閱讀

是不是又來了一個啊鏘的

突破突破突破突破突破突破突破突破突破突量滾量量滾量量滾量量滾量量滾量量滾量量滾量量滾量噴發向上📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈... 繼續閱讀

突破突破突破突破突破突破突破突破突破突量滾量量滾量量滾量量滾量量滾量量滾量量滾量量滾量噴發向上📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈

繼續閱讀

靠你們工讀生了，實踐出真知，多買點。用嘴巴喊無用

突破重危量滾量展現驚人的決心突破💪加油📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈... 繼續閱讀

突破重危量滾量展現驚人的決心突破💪加油📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈

要有所作為要出量展現突破重危量滾量💪加油火力全開🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥... 繼續閱讀

要有所作為要出量展現突破重危量滾量💪加油火力全開🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥

衝阿量能放大蓄勢待發噴發向上火力全開💪加油🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥... 繼續閱讀

衝阿量能放大蓄勢待發噴發向上火力全開💪加油🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥

繼續閱讀

快去洗洗睡吧 孩子

繼續閱讀

法說會這招要用幾次

量要出來了💪加油噴發向上火力全開🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀... 繼續閱讀

量要出來了💪加油噴發向上火力全開🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

繼續閱讀

不要被騙了！

和康生1783⭐️⭐️

6 月 26 日線上法說在即

海外出貨題材升溫

和康生明（26）日將出席元富證券線上法人說明會，市場關注關節注射劑赴澳洲首批出貨時程及新一代膠原敷材擴產進度。公司先前強調，其醫材列入美方最新關稅豁免清單，出口不受政策干擾，並已取得沙烏地阿拉伯、澳洲、秘魯等多國許可證。... 繼續閱讀

和康生1783⭐️⭐️

6 月 26 日線上法說在即

海外出貨題材升溫

和康生明（26）日將出席元富證券線上法人說明會，市場關注關節注射劑赴澳洲首批出貨時程及新一代膠原敷材擴產進度。公司先前強調，其醫材列入美方最新關稅豁免清單，出口不受政策干擾，並已取得沙烏地阿拉伯、澳洲、秘魯等多國許可證。  

高毛利結構+海外放量，法人看好下半年
最新資料顯示，和康生毛利率逾 71%，遠高於同業平均，搭配多國證照到手、產線擴充與股利支持，法人預期今年營收、獲利將同步走升，股價有望挑戰去年高點。

和康集團的故事--高度整合型的服務
以面膜來說：

集團每季都會設計並整合出一個面膜套組，每季研究人員都要想出不同的企劃... 繼續閱讀

和康集團的故事--高度整合型的服務
以面膜來說：

集團每季都會設計並整合出一個面膜套組，每季研究人員都要想出不同的企劃

什麼樣的精華液要配上什麼樣的功能什麼樣的精華液要配上什麼樣的不織布

這個套組可以提供客戶一個挑選的工具，
比方說：套組有森林風/海洋風/休閒風/無添加系列/香氛系列面膜

集團做產品有個重點：不管是保養品或保健品，客戶必須是享受，若保健品良藥但苦口，它就是失敗的，是不能天天做的一個保健品.

集團不停的發明企劃，提供給客戶，客戶可不停販售，甚至客戶還沒想到，研究人員就想出了解決方案.

當然好東西除了品質要一流另一個技術還要產品外表要好看.

未完待續

本資料謹供參考，純屬虛構，如有雷同，投資人請獨立判斷，並自負投資風險.

上週選出的偉訓3032，開盤強勢漲停

再來分享一檔

⭐️台灣生醫材料廠和康生（1783）再傳捷報。

公司今（24）日股價早盤一度來到... 繼續閱讀

上週選出的偉訓3032，開盤強勢漲停

再來分享一檔

⭐️台灣生醫材料廠和康生（1783）再傳捷報。

公司今（24）日股價早盤一度來到 43.9 元，較前一交易日上漲 0.92%，在盤勢震盪中顯現買盤支撐。 

5 月營收連兩位數成長，累計前五月年增近 26%
和康生公告 2025 年 5 月合併營收 7,702.1 萬元，年增 18.55%；累計前五月營收 3.07 億元，年增 25.81%，創歷史新高⭐️，顯示訂單動能持續擴大。 

首季毛利率逾 70%，EPS 較去年大增六成
第一季財報亦亮眼：營收 1.77 億元，年增 39.45%；毛利率達 70.68%；歸屬母公司淨利 4,708.8 萬元，EPS 0.53 元，較去年同期成長 65.7%。 

海外布局開花結果，醫材列「關稅豁免」無懼貿易波動
公司指出，關節注射劑已取得沙烏地阿拉伯、澳洲與秘魯上市許可，澳洲預計第二季正式出貨；膠原敷材也相繼打入越南、泰國市場，新一代鼻腔敷料更於美國、台灣開賣。醫材屬美方最新關稅豁免名單，出口不受影響。 

⭐️法說會將登場，後市題材受矚目
和康生將於 6 月 26 日參加元富證券線上法人說明會，預料將釋出下半年成長藍圖與臨床產品進度，吸引市場關注。 

發言人陳嬿娟表示：「隨著海外許可證陸續到手，第二季起新市場貢獻度將顯著放大。我們維持今年營收雙位數成長目標不變。」

法人觀點
多家法人認為，和康生具備高毛利醫材組合、關鍵市場放量與關稅豁免三大利多，今年營運可望呈「營收、獲利雙成長」格局。若後續新品證照與海外訂單進度符合預期，股價有進一步挑戰去年高點的空間。

（以上內容僅供參考，非投資建議，投資人須自負風險）

https://youtube.com/shorts/NtaB84U1pHw 繼續閱讀

https://youtube.com/shorts/NtaB84U1pHw

https://youtube.com/shorts/NtaB84U1pHw?si=L6cYsB87mDepjuW8... 繼續閱讀

https://youtube.com/shorts/NtaB84U1pHw?si=L6cYsB87mDepjuW8

https://youtube.com/shorts/NtaB84U1pHw?si=FzkhT-oytz0ec79a... 繼續閱讀

https://youtube.com/shorts/NtaB84U1pHw?si=FzkhT-oytz0ec79a